InvestSMART

The article you are trying to access does not exist, however, here are some articles you may be interested in.

Eclipse Metals Ltd (ASX:EPM)

ALERT: Price-sensitive ASX Announcement for EPM
Current share price for EPM : $0.015 0 (0%)+
Release
29 Apr 2026 9:28AM
Price at Release
$0.015
Full Release
download
Summary
Eclipse Metals Ltd has announced a significant update to the Mineral Resource Estimate for its Grønnedal Rare Earth Element Project in Greenland, increasing the total resource estimate to 208 million tonnes with a 0.72% Total Rare Earth Oxides (TREO) content. This update represents a substantial growth from the previous estimate, including a 234% increase in tonnage and a 12% rise in grade. The project now encompasses an initial 6 million tonnes classified as Indicated and 202 million tonnes as Inferred, highlighting its potential for further development. Eclipse Metals aims to convert and expand this resource base through ongoing feasibility work and additional drilling, reinforcing the project's strategic relevance within the global supply of critical minerals.
Key Points
  • Eclipse Metals announces an update to the Mineral Resource Estimate (MRE) for the Grønnedal Rare Earth Element (REE) Project.
  • The total MRE increased to 208Mt at 0.72% TREO, a 234% increase in tonnage.
  • The resource now includes 6Mt at 0.71% REO classified as Indicated, and 202Mt at 0.72% REO classified as Inferred.
  • The updated MRE contains approximately 1.5Mt TREO, including 456,000t of Pr2O3+Nd2O3.
  • Average grade increased by 12% to 0.71% REO.
  • Further drilling is planned to expand the Indicated Resource base and support feasibility studies.
  • The project is positioned as strategically relevant within Western critical mineral supply chains.
  • Feasibility work is underway including technical, metallurgical, environmental, and infrastructure assessments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.